Latest Matter News

Pacific Edge has secured new US payer access and a Veterans Administration purchasing agreement while proposed Medicare price increases could materially lift revenue per test. The recovery remains unfinished, however, with US commercial volumes down 13% and final Medicare coverage still pending.

Indiana Resources has completed drilling at Company Well and Minos, while heritage clearance unlocks the next stage at the 7km Ealbara gold anomaly. The exploration progress comes alongside a November CEO departure and an unresolved arbitration claim over US$13.05 million in Tanzania settlement proceeds.

Ramsay Health Care has cleared the first legal step towards distributing its 52.79% stake in Ramsay Générale de Santé to shareholders. The proposed demerger now goes to consecutive shareholder meetings on 24 November, backed by the board and Deloitte’s independent expert.

Minerals Exploration has expanded its New Zealand exploration pipeline after broad gold intersections at Jubilee South and high-grade tungsten results at Invincible. The next phase is more ambitious, but A$1.96 million in cash covers only 1.91 quarters at the latest spending rate.

Gulf Stream Energy has identified oil in two separate sandstone zones at its Zydeco project in Louisiana, although the result is based solely on wireline logs and has not yet been flow-tested. The well also retains access to the undrilled Upper Tweedle gas and condensate target.

Mayne Pharma has settled its final US Paragraph IV patent dispute over IMVEXXY with Teva, setting a potential generic entry date of 2 September 2032. The agreement removes ongoing litigation without an upfront payment, while leaving court approval and earlier-entry provisions to resolve.

St Barbara reported a $489.7 million FY26 statutory profit, but almost all of it came from the deconsolidation of New Simberi Gold rather than recurring operations. The annual report also confirms a debt-free balance sheet, a 5-cent fully franked dividend and a portfolio moving from transaction-making to project delivery.

Aurum Resources has reported further high-grade gold at its BST1 deposit in Côte d’Ivoire, including mineralisation beyond the current resource that remains open at depth. The results will feed an updated Boundiali resource estimate due by the end of October and a definitive feasibility study targeted for late 2026.

Resimac Group delivered a stronger FY26, with normalised NPAT up 26% to $49.9 million and total assets under management reaching a record $16.5 billion. The result supports higher ordinary dividends, but the lender is still managing asset finance run-off, ASIC hardship proceedings and longer-term funding risks.

Vysarn delivered another year of rapid earnings growth, with revenue rising 31% and net profit after tax climbing 41% to $15.11 million. The bigger test now is whether its $65.3 million capital raise and Welltech acquisition can turn a growing collection of water businesses into a genuinely national platform.

Deep Yellow has withdrawn its target for a fourth-quarter 2026 Final Investment Decision on the Tumas uranium project, citing weak equity market conditions and constrained funding options. Construction continues, but the company has not provided a revised FID date or funding structure.

Vitura Health grew FY2026 revenue 6% to $131.2 million, but a sharp margin squeeze pushed the ASX-listed digital health company into a $4.4 million statutory loss. With ANZ debt classified as current and a potential $6 million FY2027 revenue hit from changed Bupa referrals, the promised turnaround faces a demanding test.